Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.

Authors :: Moschos SJ
Kirkwood JM
Konstantinopoulos PA
Source :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2004 Jan 01; Vol. 22 (1), pp. 11-4. Date of Electronic Publication: 2003 Dec 09.
Publication Year :: 2004

Subjects :: Antineoplastic Agents adverse effects
Biomarkers, Tumor
Chemotherapy, Adjuvant trends
Dose-Response Relationship, Drug
Humans
Melanoma physiopathology
Melanoma surgery
Prognosis
Randomized Controlled Trials as Topic
Skin Neoplasms physiopathology
Skin Neoplasms surgery
Antineoplastic Agents administration & dosage
Antineoplastic Agents therapeutic use
Interferon-alpha administration & dosage
Interferon-alpha therapeutic use
Melanoma drug therapy
Skin Neoplasms drug therapy

Language :: English
ISSN :: 0732-183X
Volume :: 22
Issue :: 1
Database :: MEDLINE
Journal :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :: Editorial & Opinion
Accession number :: 14665613
Full Text :: https://doi.org/10.1200/JCO.2004.10.952

Full Text Access

Tools